Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
TC Biopharm (Holdings) PLC
TCBP
Healthcare
Biotechnology
TC BioPharm (Holdings) plc, formerly TC BioPharm (Holdings) Limited, is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapy products that are based on its allogeneic gamma delta T (GD-T) cell platform. Harnessing the innate ability of GD-Ts, the Company has developed a range of clinical-stage cell therapies designed to combat identified cancers and...
viral infections. In addition to unmodified allogenic GD-Ts for treatment of blood cancers, it is also developing a range of genetically modified chimeric antigen receptor modified T cell (CAR-T) products for treatment of solid cancers. The Company’s pipeline includes OmnImmune, ImmuniStim, TCB009, and TCB005/TCB006. OmnImmune is an allogeneic unmodified GD-T (GD-T2) cell product, used for the treatment of Acute Myeloid Leukaemia (AML). ImmuniStim is used for the treatment of coronavirus disease (COVID-19). TCB009 is developing GD-T2 based cell therapies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:TCBP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Dec 20, 2024 8:30pm
InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP)
BREAKING NEWS: $TCBP InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Reports Positive Safety Data in ACHIEVE Phase 2b Trial for AML and MDS/AMLTC BioPharm (NASDAQ: TCBP) announced
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Dec 18, 2024 10:45am
InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP)
NEWS: $TCBP InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Special Dividend for Shareholders Amid Ongoing SupportTC BioPharm (NASDAQ: TCBP) has announced a special dividend of
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Oct 03, 2024 10:45am
TCBP Announces Artificial Intelligence Initiative with Partn
NEWS: $TCBP TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor ScreeningTCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 25, 2024 4:02pm
InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP)
BREAKING NEWS: $TCBP InvestorNewsBreaks - TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Newly Opened London-Based ACHIEVE UK Trial Site Amid 'Very Positive' Study ProgressionTC BioPharm
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 05, 2024 3:15pm
TCBP Announces Participation at the H.C. Wainwright 26th Ann
Breaking News: $TCBP TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferenceTCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 03, 2024 10:30am
TCBP Announces Dosing of 5 New Patients in ACHIEVE
NEWS: $TCBP TCBP Announces Dosing of 5 New Patients in ACHIEVETCBP Announces Dosing of 5 New Patients in ACHIEVE PR Newswire 5 New patients dosed, bringing total to 6 patients dosed in ACHIEVE at
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Aug 15, 2024 3:02pm
TC BioPharm Announces Closing of $2.0 Million Public Offerin
JUST IN: $TCBP TC BioPharm Announces Closing of $2.0 Million Public OfferingTC BioPharm Announces Closing of $2.0 Million Public Offering PR Newswire EDINBURGH, Scotland , Aug. 15, 2024 /PRNewswire/ -
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Aug 13, 2024 5:47pm
TC BioPharm Announces Pricing of $2.0 Registered Direct Offe
BREAKING NEWS: $TCBP TC BioPharm Announces Pricing of $2.0 Registered Direct OfferingTC BioPharm Announces Pricing of $2.0 Registered Direct Offering PR Newswire EDINBURGH, Scotland , Aug. 13, 2024
...more
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 07, 2024 10:07am
TCBP.....I warned you all yesterday just after the opening
$3.00 ....now at $1.25 Sure does suck being a Chaser doesn't it ; )
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 06, 2024 1:15pm
TCBP....You've all been had....again !!!!
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds 2024-05-06 10:01 ET - News Release TC BioPharm Announces Exercise of Warrants for
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 06, 2024 10:15am
TC BioPharm Announces Execution of Second Non-Binding Letter
BREAKING NEWS: $TCBP TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T TherapiesTC BioPharm Announces Execution of Second Non-Binding
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 06, 2024 10:00am
Expected earnings - TC BioPharm (Holdings) plc
JUST IN: $TCBP Expected earnings - TC BioPharm (Holdings) plcTC BioPharm (Holdings) plc (TCBP) is expected to report for Q4 2023TCBP - Expected earnings - TC BioPharm (Holdings) plc
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 04, 2024 8:32am
New Press Release - TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
EDINBURGH, Scotland, April 4, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced the execution of a non...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 02, 2024 8:31am
New Press Release - TCBP Increasing Treatment Capacity with Expanded Manufacturing Process
Developing streamlined approach to reduce cost per patient by 85%EDINBURGH, Scotland, April 2, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for...
read article.
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 20, 2024 8:43am
TCBP...might be worth another shot here
On watch ...again
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product